SAEN

Genenta Science S.p.A.

SAEN | NASDAQ
Chart Builder DCF Calculator
$0.65
-$0.05 (-7.14%)
At close: Nov 5, 2026, 4:00 PM ET
$0.67
+$0.02 (+2.46%)
After-hours: Nov 5, 2026, 4:52 PM ET

Company Profile

Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.

Key Executives

Name Position
Pierluigi Paracchi Co-Founder, Chairman, Chief Executive Officer & GM
Richard Slansky Chief Financial Officer
Barbara Regonini Finance Director
Bernard Rudolph Gentner CO-Founder & Scientific Advisory Board Member
Gianfranco De Nigris Vice President of Corporate Development
Luigi Naldini Co-Founder & Chairman of Scientific Advisory Board
Stefania Mazzoleni Director of Program Development

Latest SEC Filings

Date Type Title
Nov 02, 2026 6-K Filing
Oct 22, 2026 6-K Filing
Oct 21, 2026 6-K Filing
Oct 13, 2026 6-K Filing
Oct 07, 2026 6-K Filing
Oct 02, 2026 SC 13D/A [Amend] Filing
Sep 11, 2026 6-K Filing
Sep 02, 2026 6-K Filing
Jul 31, 2026 6-K Filing
Jul 14, 2026 6-K Filing
View All SEC Filings ➞
Genenta Science S.p.A.
SAEN
Country Italy
IPO Date Nov 4, 2026
Industry Conglomerates
Sector Industrials
Employees 9
CEO Pierluigi Paracchi

Contact Details

Via dell’Annunciata 31 Milan, Michigan 20121 Italy

Stock Details

Ticker Symbol SAEN
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001838716
CUSIP Number 36870W100
ISIN Number US36870W1009
SIC Code 2836

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.